# Definitive Healthcare Corp.: overview DH · Nasdaq · CIK 1861795 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/dh.md) · [Financials](/companies/dh/financials.md) · [Filings](/companies/dh/filings.md) · [Insiders](/companies/dh/insiders.md) Latest reported revenue: [$55.2m](/filings/0001193125-26-342488.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 10, 2026 (XBRL us-gaap:Revenues, accession 0001193125-26-342488). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [62.7](/filings/0001193125-25-269681.md) | [62.3 d](/filings/0001193125-26-076782.md) | [59.2](/filings/0001193125-26-212063.md) | [60.8](/filings/0001193125-26-342488.md) | [60.0](/filings/0001193125-25-269681.md) | [61.5 d](/filings/0001193125-26-076782.md) | [55.9](/filings/0001193125-26-212063.md) | [55.2](/filings/0001193125-26-342488.md) | | Gross margin | % | [78.2%](/filings/0001193125-25-269681.md) | [76.4% d](/filings/0001193125-26-076782.md) | [73.9%](/filings/0001193125-26-212063.md) | [76.7%](/filings/0001193125-26-342488.md) | [76.6%](/filings/0001193125-25-269681.md) | [76.2% d](/filings/0001193125-26-076782.md) | [74.5%](/filings/0001193125-26-212063.md) | [73.5%](/filings/0001193125-26-342488.md) | | Operating margin | % | [(359.5%)](/filings/0001193125-25-269681.md) | [(159.8%) d](/filings/0001193125-26-076782.md) | [(312.2%)](/filings/0001193125-26-212063.md) | [(6.9%)](/filings/0001193125-26-342488.md) | [(14.5%)](/filings/0001193125-25-269681.md) | [(43.3%) d](/filings/0001193125-26-076782.md) | [(359.9%)](/filings/0001193125-26-212063.md) | [(12.2%)](/filings/0001193125-26-342488.md) | | Net margin | % | [(208.8%)](/filings/0001193125-25-269681.md) | [(94.8%) d](/filings/0001193125-26-076782.md) | [(181.2%)](/filings/0001193125-26-212063.md) | [(12.4%)](/filings/0001193125-26-342488.md) | [(24.7%)](/filings/0001193125-25-269681.md) | [(15.1%) d](/filings/0001193125-26-076782.md) | [(247.9%)](/filings/0001193125-26-212063.md) | [(9.8%)](/filings/0001193125-26-342488.md) | | Diluted EPS | $ per share | [(1.12)](/filings/0001193125-25-269681.md) | not reported | [(0.95)](/filings/0001193125-26-212063.md) | [(0.07)](/filings/0001193125-26-342488.md) | [(0.14)](/filings/0001193125-25-269681.md) | not reported | [(1.32)](/filings/0001193125-26-212063.md) | [(0.05)](/filings/0001193125-26-342488.md) | | Free cash flow | $m | [18.7 d](/filings/0001193125-25-269681.md) | [(2.8) d](/filings/0001193125-26-076782.md) | [18.4](/filings/0001193125-26-212063.md) | [7.0 d](/filings/0001193125-26-342488.md) | [13.4 d](/filings/0001193125-25-269681.md) | [(1.7) d](/filings/0001193125-26-076782.md) | [8.4](/filings/0001193125-26-212063.md) | [8.5 d](/filings/0001193125-26-342488.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [166](/filings/0000950170-24-022134.md) | [223](/filings/0000950170-25-029086.md) | [251](/filings/0001193125-26-076782.md) | [252](/filings/0001193125-26-076782.md) | [242](/filings/0001193125-26-076782.md) | | Gross margin | % | [75.5%](/filings/0000950170-24-022134.md) | [80.9%](/filings/0000950170-25-029086.md) | [81.1%](/filings/0001193125-26-076782.md) | [78.3%](/filings/0001193125-26-076782.md) | [75.9%](/filings/0001193125-26-076782.md) | | Operating margin | % | [(16.4%)](/filings/0000950170-24-022134.md) | [(19.8%)](/filings/0000950170-25-029086.md) | [(131.2%)](/filings/0001193125-26-076782.md) | [(281.8%)](/filings/0001193125-26-076782.md) | [(92.9%)](/filings/0001193125-26-076782.md) | | Net margin | % | [(10.7%)](/filings/0000950170-24-022134.md) | [(3.2%)](/filings/0000950170-25-029086.md) | [(80.5%)](/filings/0001193125-26-076782.md) | [(163.8%)](/filings/0001193125-26-076782.md) | [(57.5%)](/filings/0001193125-26-076782.md) | | Diluted EPS | $ per share | [(0.19)](/filings/0000950170-24-022134.md) | [(0.07)](/filings/0000950170-25-029086.md) | [(1.79)](/filings/0001193125-26-076782.md) | [(3.54)](/filings/0001193125-26-076782.md) | [(1.30)](/filings/0001193125-26-076782.md) | | Free cash flow | $m | [18.5](/filings/0000950170-24-022134.md) | [27.3](/filings/0000950170-25-029086.md) | [38.2](/filings/0001193125-26-076782.md) | [45.9](/filings/0001193125-26-076782.md) | [37.1](/filings/0001193125-26-076782.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/dh/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Advent International, L.P.](/funds/1034196.md) | 2026-06-30 | $51.9m | 62,493,676 | | Unchanged | | [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $5.0m | 5,959,143 | | Reduced −84,757 | | [D. E. Shaw & Co., Inc.](/funds/1009207.md) | 2026-06-30 | $1.6m | 1,973,193 | | Reduced −126,358 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.5m | 1,829,463 | | Reduced −36,866 | | [KENNEDY CAPITAL MANAGEMENT LLC](/funds/884589.md) | 2026-06-30 | $1.4m | 1,737,044 | | New +1,737,044 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $1.2m | 1,453,209 | | Reduced −213,160 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.2m | 1,408,621 | | Reduced −1,576,946 | | [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $747.1k | 899,132 | | Added +197,109 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $457.9k | 550,753 | | Reduced −628,941 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $436.3k | 525,040 | | Added +13,900 | ## Recent filings [All 384 filings](/companies/dh/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-01 | 20:30 ET | [SCHEDULE 13D/A](/filings/0001140361-26-038313.md) | Ownership report, active investor, amended | 0001140361-26-038313 | | 2026-09-09 | 08:30 ET | [8-K](/filings/0001193125-26-385950.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-385950 | | 2026-09-02 | 09:16 ET | [8-K](/filings/0001193125-26-379460.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-379460 | | 2026-09-02 | 08:40 ET | [SCHEDULE 13D](/filings/0001193125-26-379428.md) | Ownership report, active investor | 0001193125-26-379428 | | 2026-09-02 | 08:31 ET | [8-K](/filings/0001193125-26-379420.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-379420 | | 2026-09-02 | 08:30 ET | [SCHEDULE 13D](/filings/0001140361-26-035412.md) | Ownership report, active investor | 0001140361-26-035412 | | 2026-08-10 | 16:30 ET | [10-Q](/filings/0001193125-26-342488.md) | Quarterly report, period 2026-06-30 | 0001193125-26-342488 | | 2026-08-10 | 16:10 ET | [8-K](/filings/0001193125-26-342384.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-342384 | | 2026-06-24 | 16:05 ET | [8-K](/filings/0001193125-26-281037.md) | 3.01 Delisting notice | 0001193125-26-281037 | | 2026-06-05 | 16:05 ET | [8-K](/filings/0001193125-26-259530.md) | 5.07 Shareholder vote results | 0001193125-26-259530 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-076782.md), filed Feb 26, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/e145fa54-ea91-4e15-9338-a6850d0a17b8) ## About the filer - CIK: 1861795 - Tickers: DH - Exchange: Nasdaq - SIC code: 7372 Services-Prepackaged Software - State of incorporation: DE - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 16:07 ET. No prices; not investment advice.